LEKTI Antibodies

Santa Cruz Biotechnology features a diverse variety of LEKTI Antibodies for research focused on understanding LEKTI protein functions. LEKTI Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).LEKTI, or Lymphoepithelial Kazal-type related inhibitor, is a serine protease inhibitor that plays a crucial role in regulating immune responses and maintaining skin barrier function. Its importance is demonstrated by its involvement in various skin disorders and its potential implications in cancer biology. Understanding LEKTI function is vital for advancing therapeutic strategies targeting related pathologies. LEKTI research continues to reveal new insights into cellular mechanisms and potential treatment approaches. LEKTI Antibodies enable precise detection and analysis of LEKTI expression patterns across different tissues and conditions. Advanced research techniques supported by LEKTI monoclonal antibodies help illuminate molecular pathways and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for LEKTI contribute to advancing scientific understanding of immune regulation and skin barrier function.